tiprankstipranks
Trending News
More News >
ADJUVANT HOLDINGS CO., LTD. (JP:4929)
:4929
Japanese Market

ADJUVANT HOLDINGS CO., LTD. (4929) AI Stock Analysis

Compare
0 Followers

Top Page

JP

ADJUVANT HOLDINGS CO., LTD.

(4929)

Rating:52Neutral
Price Target:
¥908.00
▲(1.00%Upside)
ADJUVANT HOLDINGS CO., LTD. faces significant valuation challenges with its high P/E ratio and overbought technical indicators. While the financial performance shows stability in certain areas, inconsistent revenue growth and profit margins remain issues. The absence of earnings call insights and corporate events further limits positive factors influencing the stock score.

ADJUVANT HOLDINGS CO., LTD. (4929) vs. iShares MSCI Japan ETF (EWJ)

ADJUVANT HOLDINGS CO., LTD. Business Overview & Revenue Model

Company DescriptionAdjuvant Holdings Co., Ltd. (4929) operates primarily in the cosmetics and healthcare sectors. The company specializes in the development, production, and distribution of beauty products, nutritional supplements, and other health-related goods. Adjuvant Holdings is known for its focus on high-quality ingredients and innovative solutions that promote wellness and enhance beauty.
How the Company Makes MoneyAdjuvant Holdings Co., Ltd. generates revenue through the sale of its cosmetics and healthcare products. The company markets its offerings through direct sales, online platforms, and strategic partnerships with retailers and distributors. Key revenue streams include the sale of skincare products, supplements, and other wellness items. Adjuvant Holdings leverages its brand reputation and product quality to attract a loyal customer base and expand its market reach. The company's earnings are further supported by collaborations with research institutions and other industry players to develop advanced formulations and technologies.

ADJUVANT HOLDINGS CO., LTD. Financial Statement Overview

Summary
ADJUVANT HOLDINGS CO., LTD. presents a mixed financial profile. Strong gross margins and a solid balance sheet provide stability, while cash flow efficiency supports operational needs. However, challenges in consistent revenue growth and profit margins suggest areas for improvement. Overall, the company's financial health is sound but requires attention to growth and profitability stability.
Income Statement
65
Positive
The company shows a volatile revenue pattern with a recent decline in revenue growth. The gross profit margin remains healthy, but net profit margins show instability due to fluctuating net income. While EBIT and EBITDA margins have improved recently, historical inconsistency affects overall performance.
Balance Sheet
75
Positive
The balance sheet is strong with a low debt-to-equity ratio, indicating prudent leverage. The equity ratio reflects a solid asset base supported by equity. Return on equity is inconsistent due to fluctuating net income, but the overall position remains stable.
Cash Flow
70
Positive
Cash flow metrics show a moderate performance with fluctuations in free cash flow growth. The operating cash flow to net income ratio is robust, indicating efficient cash generation relative to earnings. However, variability in free cash flow to net income indicates some uncertainty in cash management.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue5.48B4.10B4.44B4.38B4.43B4.89B
Gross Profit3.56B2.66B2.86B2.92B2.94B3.00B
EBITDA452.89M259.63M124.00M697.06M500.79M292.22M
Net Income147.14M40.73M-99.86M403.64M393.18M142.38M
Balance Sheet
Total Assets5.34B5.29B5.28B5.55B5.66B5.10B
Cash, Cash Equivalents and Short-Term Investments2.11B2.22B2.12B1.53B1.74B1.47B
Total Debt0.0030.51M30.82M19.18M30.08M22.96M
Total Liabilities1.10B1.11B1.06B1.06B1.34B1.00B
Stockholders Equity4.24B4.18B4.22B4.49B4.32B4.09B
Cash Flow
Free Cash Flow54.91M301.91M314.89M-422.66M369.44M317.90M
Operating Cash Flow54.91M307.99M377.61M-321.67M417.88M403.11M
Investing Cash Flow0.00-95.61M391.20M344.97M24.39M-235.19M
Financing Cash Flow0.00-104.55M-198.21M-256.90M-179.73M-169.56M

ADJUVANT HOLDINGS CO., LTD. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price899.00
Price Trends
50DMA
760.44
Positive
100DMA
782.59
Positive
200DMA
795.18
Positive
Market Momentum
MACD
9.08
Negative
RSI
93.02
Negative
STOCH
64.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4929, the sentiment is Positive. The current price of 899 is above the 20-day moving average (MA) of 758.35, above the 50-day MA of 760.44, and above the 200-day MA of 795.18, indicating a bullish trend. The MACD of 9.08 indicates Negative momentum. The RSI at 93.02 is Negative, neither overbought nor oversold. The STOCH value of 64.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4929.

ADJUVANT HOLDINGS CO., LTD. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
¥42.90B31.17
1.37%2.52%-7.44%
69
Neutral
¥11.43B55.71
2.11%4.75%-83.63%
69
Neutral
¥7.76B10.65
-17.95%
68
Neutral
¥197.78B21.088.29%2.34%4.99%3.05%
61
Neutral
¥6.19B10.74
2.44%-2.13%
52
Neutral
¥7.22B176.82
1.33%-7.66%
45
Neutral
¥4.82B35.38
1.78%0.10%-239.09%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4929
ADJUVANT HOLDINGS CO., LTD.
899.00
30.72
3.54%
JP:4923
Cota Co., Ltd.
1,459.00
-135.38
-8.49%
JP:4925
HABA Laboratories, Inc.
1,637.00
-316.94
-16.22%
JP:4926
C'BON COSMETICS Co., Ltd.
1,126.00
-247.69
-18.03%
JP:4934
Premier Anti-Aging Co., Ltd.
890.00
-18.00
-1.98%
JP:4936
AXXZIA, Inc.
474.00
-559.84
-54.15%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 05, 2025